Cellectis Statistics

Total Valuation

Cellectis has a market cap or net worth of GBP 87.28 million. The enterprise value is 62.18 million.

Market Cap	87.28M
Enterprise Value	62.18M

Important Dates

The next estimated earnings date is Monday, August 4, 2025.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	72.29M
Shares Outstanding	n/a
Shares Change (YoY)	+57.25%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	38.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.06
PB Ratio	0.97
P/TBV Ratio	0.97
P/FCF Ratio	4.27
P/OCF Ratio	3.87
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.33
EV / Sales	1.42
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	3.04

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.83.

Current Ratio	1.67
Quick Ratio	0.94
Debt / Equity	0.83
Debt / EBITDA	n/a
Debt / FCF	3.65
Interest Coverage	-7.09

Financial Efficiency

Return on equity (ROE) is -58.55% and return on invested capital (ROIC) is -16.23%.

Return on Equity (ROE)	-58.55%
Return on Assets (ROA)	-9.19%
Return on Invested Capital (ROIC)	-16.23%
Return on Capital Employed (ROCE)	-26.22%
Revenue Per Employee	193,487
Profits Per Employee	-213,932
Employee Count	222
Asset Turnover	0.15
Inventory Turnover	n/a

Taxes

In the past 12 months, Cellectis has paid 202,785 in taxes.

Income Tax	202,785
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.27% in the last 52 weeks. The beta is 3.20, so Cellectis's price volatility has been higher than the market average.

Beta (5Y)	3.20
52-Week Price Change	-30.27%
50-Day Moving Average	1.34
200-Day Moving Average	1.53
Relative Strength Index (RSI)	60.17
Average Volume (20 Days)	942

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cellectis had revenue of GBP 42.37 million and -46.85 million in losses. Loss per share was -0.48.

Revenue	42.37M
Gross Profit	42.37M
Operating Income	-40.90M
Pretax Income	-46.65M
Net Income	-46.85M
EBITDA	-31.77M
EBIT	-40.90M
Loss Per Share	-0.48

Full Income Statement

Balance Sheet

The company has 98.79 million in cash and 74.48 million in debt, giving a net cash position of 24.31 million.

Cash & Cash Equivalents	98.79M
Total Debt	74.48M
Net Cash	24.31M
Net Cash Per Share	n/a
Equity (Book Value)	89.94M
Book Value Per Share	1.24
Working Capital	84.56M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 22.56 million and capital expenditures -2.14 million, giving a free cash flow of 20.42 million.

Operating Cash Flow	22.56M
Capital Expenditures	-2.14M
Free Cash Flow	20.42M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -96.52% and -110.57%.

Gross Margin	100.00%
Operating Margin	-96.52%
Pretax Margin	-110.09%
Profit Margin	-110.57%
EBITDA Margin	-74.98%
EBIT Margin	-96.52%
FCF Margin	48.19%

Dividends & Yields

Cellectis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-57.25%
Shareholder Yield	n/a
Earnings Yield	-53.68%
FCF Yield	23.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cellectis has an Altman Z-Score of -0.95 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.95
Piotroski F-Score	5